Use of electrospray ionization liquid chromatography-mass spectrometry to study the role of CYP2D6 in the in vitro metabolism of 5-hydroxytryptamine receptor antagonists.
@article{Sanwald1996UseOE, title={Use of electrospray ionization liquid chromatography-mass spectrometry to study the role of CYP2D6 in the in vitro metabolism of 5-hydroxytryptamine receptor antagonists.}, author={P. Sanwald and M. David and J. Dow}, journal={Journal of chromatography. B, Biomedical applications}, year={1996}, volume={678 1}, pages={ 53-61 } }
An electrospray ionization liquid chromatographic-mass spectrometric (ESI-LC-MS) method has been developed to study the involvement of the cytochrome P450 isoenzyme CYP2D6 in the in vitro metabolism of the indole containing 5-hydroxytryptamine (5-HT(3)++) receptor antagonists tropisetron, ondansetron and dolasetron in human liver microsomes. Compounds were eluted using linear gradients of acetonitrile-20 mM ammonium acetate, solvent A, (10:90, v/v) (pH 6.0) and solvent B, (60:40, v/v) (pH 6.0… CONTINUE READING
Topics from this paper
18 Citations
Determination of ondansetron and its hydroxy metabolites in human serum using solid-phase extraction and liquid chromatography/positive ion electrospray tandem mass spectrometry.
- Chemistry, Medicine
- Journal of mass spectrometry : JMS
- 2000
- 18
Electrospray mass spectrometric studies of noncovalent complexes of buspirone hydrochloride and other serotonin 5-HT(1A) receptor ligands containing arylpiperazine moieties.
- Chemistry, Medicine
- Rapid communications in mass spectrometry : RCM
- 2003
- 3
Determination of tropisetron in human plasma by liquid chromatography-tandem mass spectrometry.
- Chemistry, Medicine
- Journal of pharmaceutical and biomedical analysis
- 2009
- 16
Measurement and pharmacokinetic study of unbound tropisetron in rat blood by microdialysis with high-performance liquid chromatography.
- Chemistry, Medicine
- International journal of pharmaceutics
- 1999
- 10
Determination of Tropisetron in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry
- Chemistry
- 2010
- 4
The metabolism of the 5HT3 antagonists ondansetron, alosetron and GR87442 I: A comparison of in vitro and in vivo metabolism and in vitro enzyme kinetics in rat, dog and human hepatocytes, microsomes and recombinant human enzymes
- Biology, Medicine
- Xenobiotica; the fate of foreign compounds in biological systems
- 2007
- 12
Development and validation of a rapid 96-well format based liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analysis method for ondansetron in human plasma.
- Chemistry, Medicine
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
- 2006
- 27
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
- Biology, Medicine
- Clinical pharmacokinetics
- 2009
- 337
References
SHOWING 1-10 OF 13 REFERENCES
Use of electrospray ionization and neutral loss liquid chromatography/tandem mass spectrometry in drug metabolism studies
- Chemistry
- 1995
- 41
Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies.
- Chemistry, Medicine
- Journal of medicinal chemistry
- 1993
- 139
The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.
- Chemistry, Medicine
- Drug metabolism and disposition: the biological fate of chemicals
- 1994
- 92
Stereoselectivity of the carbonyl reduction of dolasetron in rats, dogs, and humans.
- Chemistry, Medicine
- Chirality
- 1995
- 24
Identification of the primary gene defect at the cytochrome P450 CYP2D locus
- Biology, Medicine
- Nature
- 1990
- 299
The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms.
- Biology, Medicine
- Pharmacology & therapeutics
- 1990
- 140
Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism.
- Chemistry, Medicine
- British journal of clinical pharmacology
- 1990
- 33
A predictive model for substrates of cytochrome P450-debrisoquine (2D6).
- Chemistry, Medicine
- Chemical research in toxicology
- 1992
- 134
The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects.
- Biology, Medicine
- Pharmacology & therapeutics
- 1990
- 391